These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28872276)

  • 41. Early diagnosis of in utero and intrapartum HIV infection in infants prior to 6 weeks of age.
    Lilian RR; Kalk E; Bhowan K; Berrie L; Carmona S; Technau K; Sherman GG
    J Clin Microbiol; 2012 Jul; 50(7):2373-7. PubMed ID: 22518871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Newborn screening for human immunodeficiency virus infection in the Bronx, NY, and evolving public health policy.
    McNeeley DF; Laroche L; Bhutra S; Suarez E; Rao S; Rajegowda B
    Am J Perinatol; 1999; 16(10):503-7. PubMed ID: 10874985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterizing Viral Load Burden Among HIV-Infected Women Around the Time of Delivery: Findings From Four Tertiary Obstetric Units in Gauteng, South Africa.
    Moyo F; Haeri Mazanderani A; Murray T; Technau KG; Carmona S; Kufa T; Sherman GG
    J Acquir Immune Defic Syndr; 2020 Apr; 83(4):390-396. PubMed ID: 31914002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance of Roche CAP/CTM HIV-1 qualitative test version 2.0 using dried blood spots for early infant diagnosis.
    Gueye SB; Diop-Ndiaye H; Diallo MM; Ly O; Sow-Ndoye A; Diagne-Gueye ND; Kébé-Fall K; Diop F; Gaye-Diallo A; Belec L; Mboup S; Touré-Kane C
    J Virol Methods; 2016 Mar; 229():12-5. PubMed ID: 26706730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic value of viral culture, polymerase chain reaction and western blot for HIV-1 infection in 218 infants born to HIV-infected mothers and examined at different ages.
    Cattaneo E; Zavattoni M; Baldanti F; Sarasini A; Caselli D; Maccabruni A; Martegani R; Torre D; Revello MG; Gerna G
    New Microbiol; 1999 Oct; 22(4):281-91. PubMed ID: 10555197
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors associated with non-attendance at scheduled infant follow-up visits in an observational cohort of HIV-exposed infants in South Africa, 2012-2014.
    Ngandu NK; Jackson D; Lombard C; Nsibande DF; Dinh TH; Magasana V; Mogashoa M; Goga AE
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):788. PubMed ID: 31526372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.
    American Academy of Pediatrics Committee on Pediatric AIDS
    Pediatrics; 2008 Nov; 122(5):1127-34. PubMed ID: 18977995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of four commercial virological assays for early infant HIV-1 diagnosis using dried blood specimens.
    Alvarez P; Prieto L; Martín L; Obiang J; Avedillo P; Vargas A; Rojo P; Fernández McPhee C; Sanz Canalejas L; Benito A; Ramos JT; Holguín Á
    Pediatr Res; 2017 Jan; 81(1-1):80-87. PubMed ID: 27653084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Introducing a multi-site program for early diagnosis of HIV infection among HIV-exposed infants in Tanzania.
    Nuwagaba-Biribonwoha H; Werq-Semo B; Abdallah A; Cunningham A; Gamaliel JG; Mtunga S; Nankabirwa V; Malisa I; Gonzalez LF; Massambu C; Nash D; Justman J; Abrams EJ
    BMC Pediatr; 2010 Jun; 10():44. PubMed ID: 20565786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the performance of Abbott m2000 and Roche COBAS Ampliprep/COBAS Taqman assays for HIV-1 viral load determination using dried blood spots and dried plasma spots in Kenya.
    Zeh C; Ndiege K; Inzaule S; Achieng R; Williamson J; Chih-Wei Chang J; Ellenberger D; Nkengasong J
    PLoS One; 2017; 12(6):e0179316. PubMed ID: 28622370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An analysis of the HIV testing cascade of a group of HIV-exposed infants from birth to 18 months in peri-urban Khayelitsha, South Africa.
    Nelson AK; Cassidy T; Trivino Duran L; Cox V; Wedderburn CJ; Giddy J; Pieters P; Cotton MF; Mutseyekwa T; Rorwana B; Sibanda B; Bernheimer J; Matise N; Isaakidis P; Maritz J
    PLoS One; 2022; 17(1):e0262518. PubMed ID: 35030227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. The HIV Infection in Newborns French Collaborative Study Group.
    Burgard M; Mayaux MJ; Blanche S; Ferroni A; Guihard-Moscato ML; Allemon MC; Ciraru-Vigneron N; Firtion G; Floch C; Guillot F
    N Engl J Med; 1992 Oct; 327(17):1192-7. PubMed ID: 1406792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimating the cost of diagnosing HIV at birth in Lesotho.
    Tchuenche M; Gill MM; Bollinger L; Mofenson L; Phalatse M; Nchephe M; Mokone M; Tukei V; Tiam A; Forsythe S
    PLoS One; 2018; 13(8):e0202420. PubMed ID: 30110377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiretroviral Treatment Initiated in the First Month of Life.
    Frigati L; Wynberg E; Maritz J; Holgate S; Cotton MF; Rabie H
    Pediatr Infect Dis J; 2017 Jun; 36(6):584-587. PubMed ID: 28027284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of polymerase chain reaction in early diagnosis of human immunodeficiency virus infection in infants.
    Lukong CS; Tshimwanga ED; Mfuh AY
    Ann Afr Med; 2013; 12(4):232-5. PubMed ID: 24309412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss to Follow-Up within the Prevention of Mother-to-Child Transmission Care Cascade in a Large ART Program in Nigeria.
    Rawizza HE; Chang CA; Chaplin B; Ahmed IA; Meloni ST; Oyebode T; Banigbe B; Sagay AS; Adewole IF; Okonkwo P; Kanki PJ;
    Curr HIV Res; 2015; 13(3):201-9. PubMed ID: 25986371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals.
    Taylor N; Schmid I; Egle A; Greil R; Patsch W; Oberkofler H
    Antivir Ther; 2009; 14(8):1189-93. PubMed ID: 20032549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test: comparison with the Cobas Amplicor HIV-1 Monitor test (manual specimen preparation).
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2002 Dec; 25 Suppl 3():S103-7. PubMed ID: 12467784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation of dilution of plasma samples with phosphate buffered saline to eliminate the problem of small volumes associated with children infected with HIV-1 for viral load testing using Cobas AmpliPrep/COBAS TaqMan HIV-1 test, version 2.0 (CAP CTM HIV v2.0).
    Mine M; Nkoane T; Sebetso G; Sakyi B; Makhaola K; Gaolathe T
    J Virol Methods; 2013 Dec; 194(1-2):217-21. PubMed ID: 24025342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 (CAP/CTM v2.0) with other real-time PCR assays in HIV-1 monitoring and follow-up of low-level viral loads.
    Wojewoda CM; Spahlinger T; Harmon ML; Schnellinger B; Li Q; Dejelo C; Schmotzer C; Zhou L
    J Virol Methods; 2013 Jan; 187(1):1-5. PubMed ID: 23098667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.